Ładuje się......
Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden
This database study compares surveillance data on immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitors to determine whether irAEs experienced during anti–PD-1 therapy correlate with tumor mutational burden across 18 cancer types.
Zapisane w:
| Wydane w: | JAMA Oncol |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Medical Association
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6707013/ https://ncbi.nlm.nih.gov/pubmed/31436791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.3221 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|